Document Type : Original Article

Authors

1 Dept. of Oral Pathology, University of Ibadan, University College Hospital, Ibadan, Oyo State, Nigeria.

2 Dept. of Oral Pathology, University College Hospital, Ibadan, Oyo State, Nigeria.

10.30476/dentjods.2023.96389.1935

Abstract

Statement of the Problem: Fibro-osseous lesions (FLs), may rarely exhibit malignant features likewise undergo malignant transformation. Awareness of these features can assist in screening for potentially malignant cases and identifying low-grade central osteogenic sarcoma (LGCOS) that may mimic FLs.
Purpose: The objective of this study was to determine the usability of an index in predicting malignant changes in jaw FLs.
Materials and Method: This was a retrospective study where hematoxylin and eosin (H&E) slides and archival records of fibrous dysplasia (FD) and ossifying fibroma (OF) cases were reviewed. The sections were assessed for permeation of marrow spaces, stromal growth pattern, cytologic atypia, mitotic activity, and pattern of bone growth, which are parameters for diagnosing LGCOS. The predictive histologic index of malignancy (PHIM) was determined by a sum of the scores and graded as 0=nil, 1=low, 2 & 3=moderate, and 4 & 5=high. Data were presented using descriptive analysis.
Results: Ninety-three cases of FLs met the inclusion criteria, consisting of 40(43%) cases of FD and 53(57%) cases of OF. The peak age of presentation for FD and OF was 2nd and 3rd decade. There was a female preponderance of 1:1.6. The maxilla was the most common site affected by FD, while the mandible was most commonly affected by OF. For FD cases, the PHIM was moderate in 10(25%) cases and low in 21(52.5%) cases. Similarly, for OF cases, 30(56.6%) cases had low grade PHIM while 10(17%) cases had moderate grade PHIM.
Conclusion: The PHIM depicted low to moderate malignancy grade in some of the cases studied. Follow up studies would be necessary to assess the PHIM.

Highlights

Akindayo Olufunto Akinyamoju (Google Scholar)

Keywords

  • Netto JD, Cerri JM, Miranda ÁM, Pires FR. Benign fibro-osseous lesions: clinicopathologic features from 143 cases diagnosed in an oral diagnosis setting. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 115: e56–e65.
  • Lasisi TJ, Adisa AO, Olusanya AA. Fibro-osseous lesions of the jaws in Ibadan Nigeria. Oral Health Dent Manag. 2014; 13: 41-44.
  • Prabhu S, Sharanya S, Naik PM, Reddy A, Patil V, Pandey S, et al. Fibro-osseous lesions of the oral and maxillo-facial region: Retrospective analysis for 20 years. J Oral Maxillofac Pathol. 2013; 17: 36–40.
  • Pereira TD, Gomes CC, Brennan PA, Fonseca FP, Gomez RS. Fibrous dysplasia of the jaws: Integrating molecular pathogenesis with clinical, radiological, and histopathological features. J Oral Pathol Med. 2019; 48: 3-9.
  • Rageh OA. Fibrous dysplasia-a review article. IOSR J Dent Med Sci. 2017; 16: 54-60.
  • Bartl R, Bartl C. Fibrous dysplasia. In: Bone Disorders. 1th ed. Switzerland: Springer; 2017. p. 377-380.
  • Davidova LA, Bhattacharyya I, Islam MN, Cohen DM, Fitzpatrick SG. An analysis of clinical and histopathologic features of fibrous dysplasia of the jaws: a series of 40 cases and review of literature. Head Neck Pathol. 2020; 14: 353-361.
  • Guruprasad Y, Prabhakar C. Craniofacial polyostotic fibrous dysplasia. Contemp Clin Dent. 2010; 1: 177 -179.
  • Yang L, Wu H, Lu J, Teng L. Prevalence of different forms and involved bones of craniofacial fibrous dysplasia. J Craniofac Surg. 2017; 28: 21-25.
  • Kashima TG, Gamage NM, Ye H, Amary MF, Flanagan AM, Ostlere SJ, et al. Locally aggressive fibrous dysplasia. Virchows Arch. 2013; 463: 79-84.
  • Bonar SF. Central low-grade osteosarcoma: a diagnostic challenge. Skeletal Radiol. 2012; 4: 365-367.
  • Arnold JP, Smith CJ, González Torres KE, Jenzer AC. Low-grade central osteosarcoma of the mandible clinically mimicking a benign fibro-osseous lesion: A rare case report. Dent Oral Maxillofac Res. 2020; doi: 10.15761/ DOMR.1000328
  • Saikrishna D, Shetty S, Ramya S. Massive ossifying fibroma of mandible. Ann Maxillofac Surg. 2014; 4: 81-84.
  • Abtahi J, Ajan A. Malignant transformation of ossifying fibroma into parosteal osteosarcoma with high-grade component: presentation of an unusual case and review of the literature. The Open Dent J. 2018; 12: 1059-1068.
  • Olusanya AA, Adeyemi BF, Adisa AO. Concurrent cemento-osseous dysplasia and osteogenic sarcoma: report of two cases. Case Rep Med. 2012; 2012: 180561.
  • Inwards CY. Low-grade central osteosarcoma versus fibrous dysplasia. Pathol Case Rev. 2001; 6: 22-27.
  • Lee YB, Kim NK, Kim JY, Kim HJ. Low-grade osteosarcoma arising from cemento-ossifying fibroma: a case report. J Korean Assoc Oral Maxillofac Surg. 2015; 41: 48-51.
  • Li Z, Raynald, Wang Z, Qian H. Malignant transformation of craniofacial fibrous dysplasia: a systematic review of overall survival. Neurosurg Rev. 2020; 43: 911-921.
  • Gibson-Corley KN, Olivier AK, Meyerholz DK. Principles for valid histopathologic scoring in research. Vet Pathol. 2013; 50: 1007-1015.
  • Dube NC, Moshy JR, Vuhahula EA, Sohal KS. Benign fibro-osseous lesions of the jaws: a clinicopathologic study of 98 Tanzanian patients. J Oral Med Oral Surg. 2019; 25: 38.
  • Moshy J, Dimba E, Ocholla T, Chindia M. Characteristic radiological and histological patterns of fibrous dysplasia and ossifying fibroma of the jaws at University of Nairobi Dental Teaching Hospital. Surg Sci. 2012; 4: 189-193.
  • Rahman MA, Rahman T, Haider IA, Clinicopathological study of ossifying fibroma. Update Dental College Journal. 2019; 9: 7-12.
  • De*Andrade M, Silva-Sousa YT, Marques MF, Pontual ML, Ramos-Perez FM, Perez DE. Ossifying fibroma of the jaws: a clinicopathological case series study. Braz Dent J. 2013; 24: 662-666.
  • Ojo MA, Omoregie OF, Altini M, Coleman H. A clinico-pathologic review of 56 cases of ossifying fibroma of the jaws with emphasis on the histomorphologic variations. Niger J Clin Pract. 2014; 17: 619-623.
  • Davidova LA, Bhattacharyya I, Islam MN, Cohen DM, Fitzpatrick SG. An analysis of clinical and histopathologic features of fibrous dysplasia of the jaws: a series of 40 cases and review of literature. Head Neck Pathol. 2020; 14: 353-361.
  • Su CW, Tseng CH, Wang WC, Chen YK. Spontaneous osteosarcoma transformation of fibrous dysplasia in maxilla. J Dent Sci. 2019; 14: 219-222.
  • Wagner VP, Carlos R, Romañach MJ, Lopes MA, Speight PM, Vargas PA. Malignant transformation of craniomaxillofacial fibro-osseous lesions: A systematic review. J Oral Pathol Med. 2019; 48: 441-450.
  • Sugiura Y, Kanda H, Motoi N, Nomura K, Inamura K, Okada E, et al. Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene. Pathol Res Pract. 2018; 214: 318-324.
  • Salinas-Souza C, De*Andrea C, Bihl M, Kovac M, Pillay N, Forshew T, et al. GNAS mutations are not detected in parosteal and low-grade central osteosarcomas. Mod Pathol. 2015; 28: 1336-1342.
  • Tabareau-Delalande F, Collin C, Gomez-Brouchet A, Decouvelaere AV, Bouvier C, Larousserie F, et al. Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions. Mod Pathol. 2013; 26: 911-921.
  • Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010; 23:1279-1288.
  • Dujardin F, Binh MB, Bouvier C, Gomez-Brouchet A, Larousserie F, Muret A, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol. 2011; 24: 624-637.
  • Wu JX, Carpenter PM, Gresens C, Keh R, Niman H, Morris JW, et al. The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene. 1990; 5: 989-1000.